Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
DexCom Inc
DC4Current price
65.23 EUR
-0.17 EUR (-0.26%)
Last closed
65.43 EUR
Company
–
Sector
Healthcare
Industry
Medical Devices
Exchange
Berlin Exchange
Capitalization
26 993 309 311 EUR
Yield for 12 month
-30.17 %
1Y
3Y
5Y
10Y
15Y
DC4
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California. Address: 6340 Sequence Drive, San Diego, CA, United States, 92121
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
474.05 EURP/E ratio
44.7415Dividend Yield
–Current Year
+3 586 392 560 EUR
Last Year
+2 880 955 490 EUR
Current Quarter
+994 344 491 EUR
Last Quarter
+911 870 234 EUR
Current Year
+2 266 210 400 EUR
Last Year
+1 864 433 048 EUR
Current Quarter
+620 487 595 EUR
Last Quarter
+556 329 950 EUR
Key Figures DC4
1 year
3 years
5 years
10 years
EBITDA
878 009 255 EUR
Operating Margin TTM
PE Ratio
44.7415
Return On Assets TTM
6.26 %
PEG Ratio
1.3704
Return On Equity TTM
29.41 %
Wall Street Target Price
474.05 EUR
Revenue TTM
3 895 794 657 EUR
Book Value
6.01 EUR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
15.3 %
Dividend Yield
–
Gross Profit TTM
1 864 433 048 EUR
Earnings per share
1.46 EUR
Diluted Eps TTM
1.46 EUR
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
26.6 %
Profit Margin
16.95 %
Dividend Analytics DC4
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History DC4
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
4:1
Payout Ratio
–
Last Split Date
13.06.2022
Dividend Date
–
Stock Valuation DC4
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
44.7415
Forward PE
42.735
Enterprise Value Revenue
7.4687
Price Sales TTM
6.9288
Enterprise Value EBITDA
28.4932
Price Book MRQ
11.8794
Financials DC4
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators DC4
For 52 weeks
56.24 EUR
130.57 EUR
50 Day MA
91.06 EUR
Shares Short Prior Month
–
200 Day MA
107.58 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart